PAZOTAB 200MG

Pazotab 200mg tablet contains the active ingredient pazopanib. This antineoplastic medication is classified as a tyrosine kinase inhibitor. It is prescribed for adults to treat advanced kidney cancer or cancer that has metastasized to other organs. Additionally, it is indicated for certain types of soft-tissue sarcoma, which is a cancer that affects the body’s supportive tissues. The mechanism of this medicine involves inhibiting the activity of proteins that contribute to the growth and dissemination of cancer cells.

Do not use Pazotab 200mg tablet if you have an allergy to pazopanib or any other components of this medication. Prior to starting treatment, it is essential to inform your healthcare provider if you have any kidney, heart, lung, or liver issues, bleeding disorders, gastrointestinal problems, or thyroid conditions. This tablet may elevate your blood pressure, so it is important to monitor your blood pressure regularly throughout the treatment. No dosage modifications are necessary for patients with kidney conditions.

Your physician will instruct you to discontinue Pazotab 200mg tablet at least 7 days prior to any surgical or dental procedures you may have, as it could interfere with the healing of wounds. This medication is not advised for individuals under the age of 18. It may lead to infertility; therefore, consult your healthcare provider before using this medication. The most frequently reported side effects include diarrhea, hypertension, changes in hair color, nausea, and vomiting.